Scientists at Roche Molecular Systems have been exploring using the 454 Life Sciences GS FLX for high-resolution HLA DNA typing in research, an application that 454 said it believes could become one of the first clinical applications of the platform.

454 says that some of its customers outside the US are close to using the 454 platform for clinical HLA typing. In addition, the company is working with the FDA to find ways to provide the system to US testing labs, some of which doubt that the platform has become robust and cheap enough for such use.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.